Adagio Medical Holdings, Inc. (ADGM)

Market Cap	23.84M
Revenue (ttm)	576,000
Net Income (ttm)	-74.74M
Shares Out	15.38M
EPS (ttm)	-7.25
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	49,861
Open	1.530
Previous Close	1.530
Day's Range	1.450 - 1.640
52-Week Range	0.625 - 9.340
Beta	0.11
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 25, 2025

About ADGM

Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company’s product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. Adagio M...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2011
• Employees: 80
• Stock Exchange: NASDAQ
• Ticker Symbol: ADGM
• Website: https://adagiomedical.com

Financial Performance

In 2024, Adagio Medical Holdings's revenue was $602,000, an increase of 100.67% compared to the previous year's $300,000. Losses were -$75.04 million, 105.1% more than in 2023.

Financial numbers in USD